BrainChip’s Akida Processor Goes to War Games as Stock Rides Out Chip Rout

BrainChip shares climb 1.5% to €0.12, extending a 14% rally. Broadcom's AI outlook drags sector, but BrainChip's Akida processor shines in Raytheon drone competition.

The semiconductor sector took a beating on Friday, dragged down by Broadcom’s tepid AI revenue outlook, but BrainChip managed to swim against the tide. The Australian AI-chip specialist saw its shares climb nearly 1.5% to €0.12, extending a seven-day rally of roughly 14%. Up more than 50% from its February 52-week low of €0.08, the stock is attracting fresh attention — not just from chart watchers, but from defense engineers on the other side of the Pacific.

The sector-wide selloff was triggered by Broadcom’s quarterly figures. While the US giant posted a 49% revenue surge to around $22 billion, its unchanged forecast for AI-related revenue of over $100 billion by 2027 disappointed markets. Marvell Technology, Intel, AMD and Qualcomm all slid in sympathy. BrainChip, by contrast, barely flinched, with traders pointing to a string of technical signals that have turned decisively bullish. The current price sits about 21% above the 50-day moving average and 16% above the 200-day line, while the relative strength index at 65.3 remains comfortably below the overbought threshold of 70.

Yet the real catalyst for the recent buzz may be playing out in California. This week, Raytheon kicked off Operation Touchdown in Santa Barbara, a competition where student engineering teams must autonomously land a drone on a moving ground vehicle. The brains of the operation is BrainChip’s neuromorphic Akida AKD1000 processor, chosen for its ability to run machine-learning inference on the edge without constant cloud connectivity and with minimal power draw. BrainChip is serving as the official technology sponsor, providing the hardware at cost and offering up to 40 hours of virtual support. No firm commercial follow-up with Raytheon has been guaranteed, but the event offers a high-profile showcase of the chip’s real-world capabilities.

That tangible use case contrasts sharply with BrainChip’s still-modest financials. The company generates annual revenue of roughly $1.9 million and remains in a developmental phase — losses are baked into the story. Analyst estimates for fair value vary wildly, ranging from A$0.34 to A$1.17 per share. The annualized 30-day volatility of 75% underscores just how speculative the stock remains. Management recently corrected a filing with the Australian Securities Exchange, trimming the number of outstanding restricted share units to around 34 million — a move seen by observers as administrative hygiene aimed at limiting shareholder dilution.

For now, the rally is driven more by mood than milestones. The Akida processor is proving its mettle in a military-grade stress test, and the stock’s technical picture is improving. But until licensing fees start flowing from actual industrial customers, the recent gains remain a bet on potential rather than profits.